NXS — Next Science Share News
0.000.00%
HealthcareSpeculativeMicro Cap
- AU$42.36m
- AU$48.62m
- $22.82m
Brief: Next Science Says CEO & Managing Director I.V. Hall, and CFO Marc Zimmerman Resigned
Brief: Next Science Releases Quarterly Activity Report
Australia's Next Science surges on sale of assets for $50 million
Brief: Next Science To Sell Majority Of Assets
Brief: Next Science Says Derivative Complaint Filed By Individual Been Dismissed By Court
Brief: Next Science Says 1Q FY25 Product Sales Of $5.3M
Brief: Next Science Posts Loss For The Year Of $10.6 Mln
Brief: Next Science Receives FDA Warning Letter
Brief: Next Science Posts FY24 Revenue Of $22.8M
Australia's Next Science plunges on litigation filed by ex-employee
Brief: Next Science Announces Litigation Involving Former Employee
Brief: Next Science Posts 3Q FY24 Product Sales Of $4.7 Mln
Brief: Next Science Says Loss For Year Attributable Us$5.8 Million
Brief: Next Science Says Expect To Be Adjusted EBITDA Positive In 4Q Fy24/1Q Fy25
Brief: Next Science Posts HY Revenue And Product Sales Of $11.2M
Brief: Next Science To Remove Revenue Guidance For FY24
Brief: Next Science Ltd Reports 2Q Fy24 Gross Margin Of 80%
Brief: Next Science Ltd Says Next Science Enters Into Us$5M Unsecured Loan Facility
Australia's Next Science rises on positive FY24 forecast